Tecan uses cookies to improve our website. By continuing to browse our website, you accept our cookie policy.
Tecan uses cookies to improve our website. By continuing to browse our website, you accept our cookie policy.
When the SARS-CoV-2 pandemic hit in 2020, researchers from the Hubrecht Institute in Utrecht, Netherlands, felt compelled to support the national COVID-19 testing strategy, which was suffering with limited capacity. Recognizing that the gold...
G-protein coupled receptors (GPCRs) have an integral role in the development of various diseases, and are therefore a key focus for many researchers investigating novel drug targets or attempting to understand more about human health. Scientists at...
GAP Peptides has developed a novel approach to synthesizing high crude purity peptides that minimizes solvent and raw material consumption, while simultaneously reducing waste. Laboratory automation is helping this start-up company to accelerate its...
Stem cell research has seen explosive growth in recent years, with the technology holding promise for the treatment and cure of a wide range of conditions, from cancer, diabetes and heart disease to neurological conditions, inherited disorders and...
Automation offers many benefits for bioprocess development involving multiple microbial strains, yet few off-the-shelf platforms are capable of combining liquid handling tasks with microscale cultivation. The Microbial Bioprocess Lab at...
Degenerative eye diseases affect millions of people around the world, causing progressive loss of vision and, in some cases, complete blindness. Researchers in Australia are using stem cell technologies to investigate ways of halting, or even...
The High Throughput Omics Platform is an advanced microbial cultivation and sampling system designed to accelerate the development of novel biotechnology applications. Created as a collaboration between LISBP and the Tecan Integration Group, this...
Scientists in the ADME Screening, Enzymology and Automation Group at Roche, Switzerland, have successfully integrated a mosquito® nanoliter liquid handling instrument with a Freedom EVO® platform, enabling accurate, precise pipetting at very low...
Basel-based Novartis Pharma AG has completed a year-long collaboration with the Tecan Integration Group, developing a fully automated Freedom EVO®-based system for antibody formulation screening.
The Leibniz-Institut für Molekulare Pharmakologie is using Tecan's Freedom EVO® workstations for systematic high throughput screening of bioactive small molecule libraries for potential research tools and targets for drug development.